Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
46 hedge funds and large institutions have $127M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2% more funds holding
Funds holding: 45 → 46 (+1)
1% more call options, than puts
Call options by funds: $115K | Put options by funds: $114K
6% less capital invested
Capital invested by funds: $135M → $127M (-$7.45M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.1M |
| 2 |
BlackRock
New York
|
+$1.63M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$1.44M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$825K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$555K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$1.87M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$1.79M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$1.47M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$1.26M |
| 5 |
Renaissance Technologies
New York
|
-$905K |
NBRV Hedge Fund Activity: Q1 2018 in Review
46 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q1 2018, worth a combined $127M — down 5.5% from $135M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NBRV positions and 6 closed out — a net gain of 1 holder — while 9 added to existing stakes and 17 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $20.1M. The largest seller was Franklin Resources, cutting an estimated $1.87M.
- 46 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q1 2018, up from 45 in Q4 2017.
- Funds reported $127M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q1 2018, down 5.5% quarter-over-quarter.
- 7 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q1 2018 and 6 closed out, a net change of +1 holder.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q1 2018 was Wellington Management Group, an estimated $20.1M added.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q1 2018 was Franklin Resources, an estimated $1.87M sold.
Based on aggregated 13F filings for Q1 2018.